{"id":22677,"date":"2024-04-05T13:27:27","date_gmt":"2024-04-05T17:27:27","guid":{"rendered":"https:\/\/medicarereport.org\/?p=22677"},"modified":"2024-04-05T13:27:29","modified_gmt":"2024-04-05T17:27:29","slug":"ozempic-predecessor-may-slow-parkinsons-progression-new-study-shows","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=22677","title":{"rendered":"Ozempic predecessor may slow Parkinson&#8217;s progression, new study shows"},"content":{"rendered":"\n<p>By Erica Carbajal for Becker&#8217;s Hospital Review on April 4, 2024<\/p>\n\n\n\n<p>A small study has found lixisenatide, a GLP-1 made by Sanofi, may slow the progression of Parkinson&#8217;s disease, according to findings published April 3 in\u00a0The New England Journal of Medicine. <a href=\"https:\/\/www.beckershospitalreview.com\/glp-1s\/ozempic-predecessor-may-slow-parkinsons-progression-new-study-shows.html\">Here&#8230;<\/a><\/p>\n\n\n\n<p> <img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"113\" class=\"wp-image-7803\" style=\"width: 150px;\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/medical-research-medicare-hospital-physician-.jpg\" alt=\"\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/medical-research-medicare-hospital-physician-.jpg 700w, https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/medical-research-medicare-hospital-physician--300x225.jpg 300w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/><\/p>\n\n\n\n<p class=\"has-small-font-size\"><strong>Notice:<\/strong>&nbsp;The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>By Erica Carbajal for Becker&#8217;s Hospital Review on April 4, 2024 A small study has found lixisenatide, a GLP-1 made<\/p>\n","protected":false},"author":10,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12,15],"tags":[1236,1237,965],"class_list":["post-22677","post","type-post","status-publish","format-standard","hentry","category-health-care-general","category-part-dprescription-drugs","tag-glp-1","tag-medicincal-research","tag-parkinsons-disease"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/22677","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=22677"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/22677\/revisions"}],"predecessor-version":[{"id":22678,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/22677\/revisions\/22678"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=22677"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=22677"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=22677"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}